Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer

NCT01186601 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: PET tracer (BAY94-9392)

Sponsor

Life Molecular Imaging SA